Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
URGN | UroGen Pharma Ltd. | Chief Executive Officer | $5.88M | Jan 31, 2024 | ||
ALLO | Allogene Therapeutics, Inc. | Director | Jun 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|